Cellectar Biosciences Inc (CLRB) — Net Asset Momentum
Cellectar Biosciences Inc (CLRB) recorded a net asset momentum of -30.6% as of December 2025, with net assets of $9.92 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Cellectar Biosciences Inc shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Cellectar Biosciences Inc Net Asset Momentum (2004–2025)
This chart tracks Cellectar Biosciences Inc's year-over-year net asset growth across 22 annual reporting periods from 2004 to 2025. The most recent momentum reading is -30.6%, with net assets of $9.92 Million USD as of December 2025. For live market cap and overall valuation, see market cap of Cellectar Biosciences Inc.
Annual Net Asset History for Cellectar Biosciences Inc (2004–2025)
The table below shows the complete annual net asset history for Cellectar Biosciences Inc from 2004 to 2025, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is Cellectar Biosciences Inc's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $9.92 Million | $14.98 Million | $5.06 Million | ▼ -30.6% |
| 2024 | $14.29 Million | $25.47 Million | $11.18 Million | ▲ +203.8% |
| 2023 | $-13.78 Million | $12.08 Million | $25.85 Million | ▼ -244.5% |
| 2022 | $9.54 Million | $21.59 Million | $12.05 Million | ▼ -71.1% |
| 2021 | $33.05 Million | $37.20 Million | $4.16 Million | ▼ -39.7% |
| 2020 | $54.79 Million | $58.66 Million | $3.86 Million | ▲ +504.8% |
| 2019 | $9.06 Million | $12.25 Million | $3.19 Million | ▼ -31.7% |
| 2018 | $13.26 Million | $15.05 Million | $1.79 Million | ▲ +23.3% |
| 2017 | $10.75 Million | $12.87 Million | $2.12 Million | ▼ -20.6% |
| 2016 | $13.54 Million | $15.32 Million | $1.78 Million | ▲ +720.7% |
| 2015 | $1.65 Million | $7.60 Million | $5.95 Million | ▼ -84.6% |
| 2014 | $10.75 Million | $13.42 Million | $2.67 Million | ▲ +532.3% |
| 2013 | $1.70 Million | $6.82 Million | $5.12 Million | ▼ -83.3% |
| 2012 | $10.16 Million | $11.48 Million | $1.32 Million | ▲ +7.1% |
| 2011 | $9.48 Million | $10.56 Million | $1.08 Million | ▲ +685.8% |
| 2010 | $1.21 Million | $2.46 Million | $1.25 Million | ▲ +104.5% |
| 2009 | $-26.90 Million | $8.93 Million | $35.83 Million | ▼ -381.6% |
| 2008 | $-5.58 Million | $1.47 Million | $7.05 Million | ▲ +4.9% |
| 2007 | $-5.87 Million | $11.11 Million | $16.98 Million | ▼ -155.3% |
| 2006 | $10.61 Million | $11.92 Million | $1.31 Million | ▲ +124.7% |
| 2005 | $4.72 Million | $4.94 Million | $217.16K | ▲ +208.6% |
| 2004 | $-4.35 Million | $108.57K | $4.46 Million | — |